Product Overview

Zolclik Nasal Spray is a pharmaceutical nasal spray containing Zolmitriptan, presented as Zolmitriptan Nasal Spray I.P. The product is supplied in a 0.7 mL pack with 7 metered doses and is positioned within the migraine-care segment.

For pharmaceutical distributors, PCD pharma franchise partners, stockists, pharma marketers and other B2B buyers, Zolclik offers a specialized dosage-form option that can complement a focused migraine-care or CNS-related product portfolio.

Its nasal spray presentation provides a differentiated product format compared with conventional oral dosage forms, making it a relevant consideration for pharmaceutical businesses looking to expand their product portfolio with specialized formulations.

Composition

Zolmitriptan – Nasal Spray I.P.

Exact strength should be verified from the product specification/pack artwork before publishing the strength on the website.

Product Details

Particular	Details
Brand Name	Zolclik
Generic	Zolmitriptan
Dosage Form	Nasal Spray
Pharmacopoeial Standard	I.P.
Pack Volume	0.7 mL
Dose Format	7 Metered Doses
Product Segment	Migraine Care
Company	Farlex Pharmaceuticals Pvt. Ltd.

Key Product Highlights

Zolmitriptan nasal spray formulation
7 metered-dose presentation
0.7 mL pack
Specialized nasal dosage form
Suitable for a focused migraine-care portfolio
Relevant for B2B pharmaceutical distribution and marketing
Designed for pharmaceutical business portfolios seeking differentiated dosage forms

B2B Pharma Portfolio Opportunity

The migraine-care segment includes a range of pharmaceutical formulations, and differentiated dosage forms can help pharma businesses build a more specialized portfolio.

Zolclik Nasal Spray can be considered by pharmaceutical distributors, PCD pharma franchise companies, pharma marketers and other B2B buyers looking to include a Zolmitriptan nasal spray in their product portfolio.

Its 7-metered-dose presentation and nasal delivery format provide a distinct product proposition for businesses serving appropriate healthcare channels.

Why Consider Zolclik for Your Pharma Portfolio?

A specialized formulation can add depth to a pharmaceutical product range and provide business partners with additional options within a focused therapeutic segment.

Zolclik combines:

A recognized active pharmaceutical ingredient – Zolmitriptan
Nasal spray dosage form
7 metered-dose presentation
Compact 0.7 mL pack
Specialized migraine-care positioning
B2B portfolio suitability

Packing

0.7 mL Nasal Spray – 7 Metered Doses

Please verify the final commercial packing configuration from the latest approved product specification before using it for ordering or regulatory documentation.

Ideal B2B Buyers

Zolclik Nasal Spray may be relevant for:

PCD Pharma Franchise Partners
Pharma Distributors
Stockists & Super Stockists
Pharma Marketing Companies
Pharmaceutical Product Portfolio Owners
Institutional Pharma Suppliers
Third-Party / Private Label Buyers, subject to applicable commercial and regulatory requirements

Business Enquiry

Looking to add Zolmitriptan Nasal Spray to your pharmaceutical portfolio?

Connect with Farlex Pharmaceuticals Pvt. Ltd. to enquire about product availability, commercial details, business partnership opportunities and the applicable product range.

Contact Farlex Pharmaceuticals for product and business enquiries.